Table 2b.
Study | Study Design | Population (Age) | No. of Patients (Port vs. External CVC) | Occlusion Risk (Port vs. External CVC) | P-value |
---|---|---|---|---|---|
|
|||||
Bozzetti et al. | Retrospective questionnaire | All PN patients (20–89 y) | 44 vs. 403 | 25% vs. 2% | P = 0.001 |
Howard et al. | Retrospective | All PN patients (13–74 y) | 27 vs. 48 | 0.1 vs. 0.3/1000 d | NR |
Cotogni et al. | Prospective observational | Adult patients with cancer (29–85 y) | 72 vs. 45 | 0.8 vs. 0.2/1000 d | NR |
Present study | Retrospective chart review | Pediatric patients with cancer (0.5–24 y) | 40 vs. 40 | 8.5 vs. 12.7/1000 d | P = 0.35 |
PN, parenteral nutrition; CVC, central venous catheter; CLABSI, central line–associated bloodstream infection; NR, not reported; d, day; y, year. Where data were provided separately for the PN period, this is reported.